COMMAND Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05035823 |
Recruitment Status :
Active, not recruiting
First Posted : September 5, 2021
Last Update Posted : April 23, 2024
|
Tracking Information | |||||||
---|---|---|---|---|---|---|---|
First Submitted Date ICMJE | September 1, 2021 | ||||||
First Posted Date ICMJE | September 5, 2021 | ||||||
Last Update Posted Date | April 23, 2024 | ||||||
Actual Study Start Date ICMJE | April 27, 2022 | ||||||
Estimated Primary Completion Date | August 2024 (Final data collection date for primary outcome measure) | ||||||
Current Primary Outcome Measures ICMJE |
Treatment-Related Serious Adverse Events [ Time Frame: 12 months post implant ] Number of subjects with treatment-related adverse events
|
||||||
Original Primary Outcome Measures ICMJE |
Treatment-Related Adverse Events [ Time Frame: 12 months post implant ] Number of Participants With Treatment-Related Adverse Events
|
||||||
Change History | |||||||
Current Secondary Outcome Measures ICMJE | Not Provided | ||||||
Original Secondary Outcome Measures ICMJE | Not Provided | ||||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||||
Descriptive Information | |||||||
Brief Title ICMJE | COMMAND Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis | ||||||
Official Title ICMJE | Motor NeuroProsthesis to Restore Motor Control for the COMMAND of Digital Devices: An Early Feasibility Study (EFS) of Safety in Subjects With Severe Quadriparesis | ||||||
Brief Summary | The Synchron motor neuroprosthesis (MNP) is intended to be used in subjects with severe motor impairment, unresponsive to medical or rehabilitative therapy and a persistent functioning motor cortex. The purpose of this research is to evaluate safety and feasibility. The MNP is a type of implantable brain computer interface which bypasses dysfunctional motor neurons. The device is designed to restore the transmission of neural signal from the cerebral cortex utilized for neuromuscular control of digital devices, resulting in a successful execution of non-mechanical digital commands. |
||||||
Detailed Description | Not Provided | ||||||
Study Type ICMJE | Interventional | ||||||
Study Phase ICMJE | Not Applicable | ||||||
Study Design ICMJE | Allocation: N/A Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Device Feasibility |
||||||
Condition ICMJE |
|
||||||
Intervention ICMJE | Device: Motor Neuroprosthesis (MNP)
Type of implantable brain computer interface
|
||||||
Study Arms ICMJE | Single
Implantation of the motor neuroprosthesis medical device.
Intervention: Device: Motor Neuroprosthesis (MNP)
|
||||||
Publications * | Not Provided | ||||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||
Recruitment Information | |||||||
Recruitment Status ICMJE | Active, not recruiting | ||||||
Actual Enrollment ICMJE |
6 | ||||||
Original Estimated Enrollment ICMJE | Same as current | ||||||
Estimated Study Completion Date ICMJE | August 2024 | ||||||
Estimated Primary Completion Date | August 2024 (Final data collection date for primary outcome measure) | ||||||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||||
Sex/Gender ICMJE |
|
||||||
Ages ICMJE | 21 Years to 75 Years (Adult, Older Adult) | ||||||
Accepts Healthy Volunteers ICMJE | No | ||||||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||||
Listed Location Countries ICMJE | United States | ||||||
Removed Location Countries | |||||||
Administrative Information | |||||||
NCT Number ICMJE | NCT05035823 | ||||||
Other Study ID Numbers ICMJE | S-02-01 | ||||||
Has Data Monitoring Committee | Yes | ||||||
U.S. FDA-regulated Product |
|
||||||
IPD Sharing Statement ICMJE | Not Provided | ||||||
Current Responsible Party | Synchron, Inc. ( Synchron Medical, Inc. ) | ||||||
Original Responsible Party | Same as current | ||||||
Current Study Sponsor ICMJE | Synchron Medical, Inc. | ||||||
Original Study Sponsor ICMJE | Same as current | ||||||
Collaborators ICMJE | Not Provided | ||||||
Investigators ICMJE | Not Provided | ||||||
PRS Account | Synchron, Inc. | ||||||
Verification Date | April 2024 | ||||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |